EFPIA Urges Adoption of Anticounterfeiting Measure - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

EFPIA Urges Adoption of Anticounterfeiting Measure


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

Brussels (May 30)—The European Federation of Pharmaceutical Industries and Associations (EFPIA) called for the pan-European and industry-wide adoption of 2-D barcode technology to combat the increase in counterfeit drugs in Europe.

EFPIA proposed that every medicine pack in Europe have a 2-D data-matrix barcode printed on the packaging. The barcode would be encrypted and have a randomized number that is unique to each pack, making it difficult for counterfeiters to copy the barcodes and introduce counterfeit drugs into the legitimate supply chain. The code could be read by any handheld barcode scanner and would provide a chain of custody wherever it is scanned.

Counterfeit medicines have become a subject of increasing concern in Europe.  The European Commission recently released figures that show a dramatic rise in the number of counterfeit medicines in the legitimate supply chain. The pharmaceutical industry is working to increase public awareness of the problem and come up with a feasible anticounterfeiting solution.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here